Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK inhibitors and COVID-19
Gabriel Levy, Paola Guglielmelli, Peter Langmuir, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e002838-e002838
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 164
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments
Emina Karahmet Sher, Mirna Alebić, Marijana Marković Boras, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124345-124345
Open Access | Times Cited: 15
Small molecule drug discovery targeting the JAK-STAT pathway
You Lv, Pengbing Mi, Jeffrey J. Babon, et al.
Pharmacological Research (2024) Vol. 204, pp. 107217-107217
Open Access | Times Cited: 12
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review
Michela Gasparotto, Chiara Franco, Elisabetta Zanatta, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 6, pp. 103334-103334
Open Access | Times Cited: 17
Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions
Rebecca Salomão, Victória Assis, Ivo Vieira de Sousa Neto, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 843-843
Open Access | Times Cited: 17
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 7
Shared genetics and causal associations between COVID‐19 and multiple sclerosis
Ancha Baranova, Hongbao Cao, Shaolei Teng, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 25
Qingjin Huatan decoction protects mice against influenza a virus pneumonia via the chemokine signaling pathways
Miao Liu, Fangshu Zhao, Jinke Xu, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116745-116745
Closed Access | Times Cited: 14
JAK inhibition as a new treatment strategy for patients with COVID-19
Jin Huang, Chi Zhou, Deng Jinniu, et al.
Biochemical Pharmacology (2022) Vol. 202, pp. 115162-115162
Open Access | Times Cited: 21
JAK2 inhibitor protects the septic heart through enhancing mitophagy in cardiomyocytes
Dafei Han, Tiantian Su, Mingzhu Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117279-117279
Open Access | Times Cited: 4
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19
Aurelie Guironnet-Paquet, Hind Hamzeh‐Cognasse, F. Bérard, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Anti-inflammatory agents design via the fragment hybrid strategy in the discovery of compound c1 for treating ALI and UC
Mi Guo, Yu Zou, Ke Dong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117431-117431
Closed Access
Identification of a potential miRNA–mRNA regulatory network for ischemic stroke by using bioinformatics methods: a retrospective study based on the Gene Expression Omnibus database
Zhaoying Chen, Xiaodan Zhang, Xiangjun Qi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis
Qingcong Zheng, Rongjie Lin, Yuchao Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
COVID-19 susceptibility, hospitalization and severity and the risk of brain cortical structure: a Mendelian randomization study
Derrick Sun, Zhiping Shi, Honglin Chen, et al.
QJM (2024) Vol. 117, Iss. 6, pp. 413-421
Open Access | Times Cited: 3
COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy
Mansoor Khaledi, Fatemeh Sameni, Sheida Yahyazade, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Evaluation, management and future perspectives of anal pruritus: a narrative review
Matas Jakubauskas, Audrius Dulskas
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Kappa opioid agonists in the treatment of itch: just scratching the surface?
Tyler Beck, Elena Wilson, Erik Wilkes, et al.
Itch (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 7
Cyclooxygenase-2/prostaglandin E2 pathway regulates infectious bronchitis virus replication in avian macrophages
Motamed Elsayed Mahmoud, Muhammad Umer Farooq, Ishara M. Isham, et al.
Journal of General Virology (2024) Vol. 105, Iss. 1
Closed Access | Times Cited: 2
Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review
Wen Tian, Xingxiang Ren, Mei Han, et al.
International Journal of Immunopathology and Pharmacology (2022) Vol. 36
Open Access | Times Cited: 10
Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection
Péter Lipták, Lenka Nosáková, Róbert Rosoľanka, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 1, pp. 41-51
Open Access | Times Cited: 6
Early administration of tofacitinib in COVID‐19 pneumonitis: An open randomised controlled trial
Alessia Ferrarini, Angelo Vacca, Antonio Giovanni Solimando, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 2
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top